Cargando…

Essential medicines for mental disorders: comparison of 121 national lists with WHO recommendations

BACKGROUND: To compare the medicines for mental disorders included in national essential medicines lists with the World Health Organization (WHO) essential medicines list and assess the extent to which economic status and WHO Region account for the differences. METHODS: We searched WHO repository an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Todesco, Beatrice, Ostuzzi, Giovanni, Gastaldon, Chiara, Papola, Davide, Barbui, Corrado
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850500/ https://www.ncbi.nlm.nih.gov/pubmed/36653880 http://dx.doi.org/10.1186/s13690-022-01014-x

Ejemplares similares

Calling for policy actions to increase access to long-acting antipsychotics in low-income and middle-income countries
por: Ostuzzi, Giovanni, et al.
Publicado: (2022)

Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches
por: Ostuzzi, Giovanni, et al.
Publicado: (2020)

Withdrawal Syndrome Following Discontinuation of 28 Antidepressants: Pharmacovigilance Analysis of 31,688 Reports from the WHO Spontaneous Reporting Database
por: Gastaldon, Chiara, et al.
Publicado: (2022)

Esketamine clinical trials: reply to Maju et al.
por: Gastaldon, C., et al.
Publicado: (2020)

Esketamine for treatment resistant depression: a trick of smoke and mirrors?
por: Gastaldon, C., et al.
Publicado: (2019)

Safety of psychotropic medications in people with COVID-19
por: Ostuzzi, G., et al.
Publicado: (2021)

Clinical trajectories of individuals with severe mental illness continuing and discontinuing long-acting antipsychotics: a one-year mirror-image analysis from the STAR Network Depot study
por: Ostuzzi, Giovanni, et al.
Publicado: (2023)

Mapping the selection, availability, price and affordability of essential medicines for mental health conditions at a global level
por: Todesco, B., et al.
Publicado: (2022)

Psychological and social interventions for the prevention of mental disorders in people living in low‐ and middle‐income countries affected by humanitarian crises
por: Papola, Davide, et al.
Publicado: (2020)

Poor implementation of the EU clinical trial regulation is a major threat for pragmatic trials in European countries
por: Ostuzzi, Giovanni, et al.
Publicado: (2020)

Which psychotherapy is effective in panic disorder? And which delivery formats are supported by the evidence? Study protocol for two systematic reviews and network meta-analyses
por: Papola, Davide, et al.
Publicado: (2020)

Neonatal withdrawal syndrome following in utero exposure to antidepressants: a disproportionality analysis of VigiBase, the WHO spontaneous reporting database
por: Gastaldon, C., et al.
Publicado: (2023)

CBT treatment delivery formats for panic disorder: a systematic review and network meta-analysis of randomised controlled trials
por: Papola, Davide, et al.
Publicado: (2023)

Forty years without mental hospitals in Italy
por: Barbui, Corrado, et al.
Publicado: (2018)

Selection of WHO-recommended essential medicines for non-communicable diseases on National Essential Medicines Lists
por: Jarvis, Jordan D., et al.
Publicado: (2019)

The Italian mental health-care reform: public health lessons
por: Barbui, Corrado, et al.
Publicado: (2018)

Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations
por: Ostuzzi, Giovanni, et al.
Publicado: (2020)

Correction to: Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations
por: Ostuzzi, Giovanni, et al.
Publicado: (2020)

Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO
por: Piggott, Thomas, et al.
Publicado: (2022)

Pharmacovigilance analysis of the Vigibase on neonatal withdrawal syndrome following in utero exposure to antidepressants
por: Gastaldon, C., et al.
Publicado: (2023)

A comparative analysis of the Libyan national essential medicines list and the WHO model list of essential medicines
por: Mustafa, Asma Abubakr, et al.
Publicado: (2010)

Which psychotherapy is effective in panic disorder? Findings and reflections from a systematic network meta-analysis
por: Papola, D., et al.
Publicado: (2021)

Psychotherapies for Generalized Anxiety Disorder in Adults: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials
por: Papola, Davide, et al.
Publicado: (2023)

Pharmacovigilance analysis of the Vigibase on antidepressants-related withdrawal syndrome in adults and adolescents
por: Gastaldon, C., et al.
Publicado: (2023)

NOACs Added to WHO’s Essential Medicines List: Recommendations for Future Policy Actions
por: Di Cesare, Mariachiara, et al.
Publicado: (2020)

Common mental disorders in asylum seekers and refugees: umbrella review of prevalence and intervention studies
por: Turrini, Giulia, et al.
Publicado: (2017)

Essential medicines for cancer: WHO recommendations and national priorities
por: Robertson, Jane, et al.
Publicado: (2016)

Making the use of psychotropic drugs more rational through the development of GRADE recommendations in specialist mental healthcare
por: Ostuzzi, Giovanni, et al.
Publicado: (2013)

Challenges in updating national guidelines and essential medicines lists in Sub‐Saharan African countries to include WHO‐recommended postpartum hemorrhage medicines
por: Ng'ang'a, Joyce, et al.
Publicado: (2022)

Geneva calling: WHO resolution on mental disorders
por: Barbui, Corrado, et al.
Publicado: (2012)

Comparative Analysis of ADR on China's National Essential Medicines List (2015 Edition) and WHO Model List of Essential Medicines (19th Edition)
por: Zheng, Fangfang, et al.
Publicado: (2018)

Monographs for medicines on WHO’s Model List of Essential Medicines
por: Roth, Lukas, et al.
Publicado: (2018)

Prevention and management of physical health conditions in adults with severe mental disorders: WHO recommendations
por: Gronholm, Petra C., et al.
Publicado: (2021)

Revising the WHO Essential Medicines List for paediatric rheumatology
por: Scott, Christiaan, et al.
Publicado: (2021)

National adaptation and implementation of WHO Model List of Essential Medicines: A qualitative evidence synthesis
por: Peacocke, Elizabeth F., et al.
Publicado: (2022)

Psychiatrists’ attitudes towards functional neurological disorders: results from a national survey
por: Marotta, Angela, et al.
Publicado: (2023)

Using the WHO Essential Medicines List to Assess the Appropriateness of Insurance Coverage Decisions: A Case Study of the Croatian National Medicine Reimbursement List
por: Jeličić Kadić, Antonia, et al.
Publicado: (2014)

Crossroads of methodological choices in research synthesis: insights from two network meta-analyses on preventing relapse in schizophrenia
por: Ostuzzi, Giovanni, et al.
Publicado: (2023)

Revising the WHO Essential Medicines List for paediatric rheumatology update
por: Slamang, Waheba, et al.
Publicado: (2022)

National List of Essential Medicines, 2015: Endocrinology perspective
por: Kalra, Sanjay
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_17mvljn0umld4p5h11ie5mamf0